Thomas P. O’Neill
President & CEO
Thomas P. O’Neill joined Cognivue® in April, 2018 as President and CEO. Mr. O’Neill has more than 25 years of experience leading commercial operations and a proven track record in growing revenue and EBITDA while driving operational excellence and improving customer satisfaction. Prior to joining Cognivue, Mr. O’Neill served as President, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences where he helped set the stage for long-term sustainable growth.
Prior to Qiagen, he served as the President for Hologic’s GYN, Surgical Solutions business, where he led the turnaround and significant top and bottom line growth for the Division. From 2013 to 2015, Mr. O’Neill was the President for North American Commercial Operations for Ortho Clinical Diagnostics, where he was responsible for $850 million in revenue and oversaw more than 600 professionals across all commercial functions. Under his leadership, Ortho Clinical exceeded all financial targets and restored growth to the North American business. From 2009 to 2013, Mr. O’Neill held positions of increasing responsibility at Bausch + Lomb Incorporated, most recently as Vice President and General Manager, North American Vision Care.
Prior to Bausch + Lomb, Mr. O’Neill held leadership positions at SynergEyes and Valeant Pharmaceuticals. From 1994 to 2005, he held sales and marketing positions within the Johnson and Johnson Family of Companies including Ortho-McNeil Pharmaceuticals, McNeil Consumer Healthcare and J&J/Merck. Mr. O’Neill received a B.S. in Business Administration and Marketing from the University of Akron.
Dr. Fred Ma, MD, PhD
Senior Vice President & Chief Medical Officer
Dr. Fred Ma, MD, PhD, is the Senior Vice President and Chief Medical Officer at Cognivue. His nearly four-decade career spans global pharmaceutical, medical device development and commercialization, as well as advancing neurological disorder treatments, therapies and prevention as a neurosurgeon.
Dr. Ma was most recently president and chief operating officer of Innovative Health Sciences, the immunology drug and subcutaneous drug infusion device company. He has served as chief medical officer for KORU Medical Systems, Innovacyn, and GE Healthcare, as well as leadership roles within Johnson & Johnson, Merck and elsewhere. Dr. Ma led and managed more than 100 new product developments with over 600 successful clinical trials and regulatory filings and approvals/clearances in the US, South Americas, Europe, China, Japan and Asia-Pacific region.
Before accepting his first industry position in 1990, Dr. Ma was a practicing neurosurgeon at the China-Japan Friendship Hospital in Beijing and the University of Tokyo Hospital, including tenures as attending physician and resident general chief. He received a BS/MD degree from Capital University of Medical Sciences, Beijing; a DMS (Doctor of Medical Sciences, MD/PhD) from the University of Tokyo, and a PhD in Neuroscience from Rutgers University. He is Board certified in Japan and China in neurosurgery, functional neurosurgery and oncology.
Among his many accomplishments, he has been involved in new drug research, clinical investigation and development for malignant brain tumor, mental health and cognitive modulation on Astrocytoma, Glioblastoma, ADHD, Alzheimer’s, and dementia, plus near infrared light therapy device development for TBI and PTSD.
Vice President of Finance
Samantha “Sam” McDonnell joined the Cognivue team in March 2021 as Vice President of Finance. Sam brings over 10 years of experience as a financial leader within a variety of industries including medical devices, niche manufacturing and distribution, professional services, and telecommunications. Her career has been rich in disrupting the status quo while focused on increasing operational efficiency through process improvement, software implementations, and redesigning financial models.
Prior to joining Cognivue, Sam was the CFO at a local medical device manufacturer, where she was instrumental in managing cash flow for the start-up. Prior to that, she was a member of the Willowood USA LLC executive team that strategically drove a $45M reduction of debt and maneuvered the company’s acquisition by Generic Crop Science. She has a proven track record of leading all accounting and finance functions, managing working capital, and developing forecasting models to promote operational predictability.
Sam received her MBA and B.S. from St. John Fisher College in Rochester, NY.
Vice President of Sales
Whitney Parachek joined Cognivue in August 2018 as Vice President of Sales. Ms. Parachek brings more than 20 years of commercial experience leading and developing high performance teams in the healthcare and device sector.
With a commitment to long term growth, she focuses on performance through the recruitment, development and engagement of high level talent. From 1999 – 2007 Ms. Parachek worked at CYTYC Corporation in various roles of increasing responsibility. In 2008 she joined the Hologic leadership team as part of the Cytyc acquisition. In 2014 she was promoted to Vice President of Sales for the Gynecologic Surgical Division and was tasked with the responsibility of turning around a declining business. During her three year tenure as VP of Sales, she was successful leading over 250 employees to drive double digit growth in a $400M business. In 2017 Whitney was promoted to Vice President Commercial Engagement responsible for ensuring the successful execution of long term strategic plans, engagement, and alignment of business unit integration.
She is driven by her passion to improve the lives of patients through innovative technologies, superior service, and valuable business solutions. Ms. Parachek earned a B.S. in Kinesiology from the College of Charleston in Charleston, South Carolina.
Vice President of Marketing & Strategy
Karen brings over 25 years of experience in leading strategic and commercial excellence for several Fortune 500 medical device companies and most recently private equity-backed companies. She has been employed by some of the industry’s top healthcare companies including Boston Scientific, Smith and Nephew, Sanofi, and Olympus Corporation of America.
She brings a successful track record for building global growth strategies and tactical execution plans, creating organizational structure that maximizes product launch success, and providing innovative solutions in an ever-changing healthcare environment, all leading to consecutive years of surpassing annual goals.
Prior to joining Cognivue, she served as the Vice President of Marketing for the private equity backed company Z-Medica. Over 2 years the company successfully grew their healthcare business 31% and penetrated over 65% of the Level I and II Trauma Centers in the United States. This growth led to a successful acquisition of Z-Medica by Teleflex in December of 2020.
Ms. Parkyn-Michael began her career at Boston Scientific where she held various positions in sales and marketing building the foundation for what would become a multimillion-dollar Women’s Health business. Next, she took on roles with increasing responsibilities with Smith and Nephew, Sanofi and Olympus Corporation of America. In each role she was tasked with being a change agent and bringing new thinking to these organizations to enter new markets, expedite growth with existing legacy products and determine approaches to building out the product portfolios. She has successfully launched over 50 products to the market over her career. Over these years she has consistently experienced double-digit growth trajectories due to the execution of these strategies. Additionally, she has built strong relationships and collaborated with Global Key Opinion Leaders, Healthcare Administrators, and Societal Leaders to bring new and innovative products to the market with the interest of patient care at the forefront.
Ms. Parkyn-Michael holds a Bachelor of Science degree in Business Administration from Millersville University.
Paul W. Estes
Vice President of Operations and Quality
Beginning in 2009, Paul Estes helped conceive and develop Cognivue® technology, playing integral roles in de novo 510(k) clearance from the U.S. Food and Drug Administration and its commercialization.
Today, as Director of Operations and a member of the company’s leadership team, he collaborates on planning for technology roadmaps, new product development and expansion, business relations, sales team integration, and staffing. He also holds responsibility for intellectual property management, quality and regulatory affairs, manufacturing, software development, and customer training and support.
Paul has a B.S. degree in Education from Houghton College.
Vice President of National Accounts
Jeff Keys joined Cognivue® in April 2018 as Vice President of National Accounts and is a member of the leadership team. With nearly 15 years in medical device executive and sales roles, he has grown revenues and built high performing teams by focusing on the customer experience.
At Cognivue, Jeff is collaborating with integrated delivery networks and hospital groups to gain market adoption for the company’s innovative system. He is also working closely with clinical account managers on training and sales implementation to drive market penetration and growth.
Jeff previously served as area Sales Manager for Invuity, a leader in surgical photonics, and with Intuitive Surgical, where he was instrumental in growing the adoption of robotic surgery. He also held roles with Medical Action Industries, leading an eight-state sales team. Jeff holds a B.S. in Business Administration from Nazareth College.
Vice President of Market Access
Susan is an established professional with a proven background within the medical device market of helping companies with Market Access and Business/Product Development. She has a proven track record of leading contracting, account management, partner alliances, and reimbursement teams to maximize product access and reimbursement. Susan has worked at large fortune 500 companies such as Abbott and Medtronic – along with helping start-ups Therasense and Telcare become established.